Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted From Twice-Daily to Once-Daily Tacrolimus.

Lluís Guirado,D. Burgos,Carme Cantarell,A. Fernandez,A. Franco,M.A. Gentil,A. Mazuecos,Josep Vicenç Torregrosa,Ernesto Gómez-Huertas,J.C. Ruiz,Jaime Sánchez Plumed,J Paul,R. Lauzurica,S. Zarraga,Antonio Osuna,C. Jimenez,A. Alonso,Alberto Cumpián Rodríguez,Beatriz Bardaji,Domingo Hernández

Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted From Twice-Daily to Once-Daily Tacrolimus.

2015

Background There is some evidence pointing toward better renal function in kidney transplant recipients (KTR) treated with once-daily tacrolimus (QD-TAC) vs. twice-daily tacrolimus (BID-TAC).

Keywords:

Renal function
Urology
Cohort
Tacrolimus
Medicine
Kidney
large cohort
kidney transplant
once daily
medium term

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations